Advance Search

Shifting the mean incident age for the five screenable cancers in Sulaymaniyah city-Iraq toward the younger age group, as a single-city experience for the last 12 years

Dara Rashid Mahmud
Ministry of Planning, Erbil, Kurdistan region, Iraq.
Keywords:
Copyright and Licensing:

Copyright (c) 2025 Dara Rashid Mahmud (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Share:
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Background and objective: Recent trends have indicated a shift in the mean incident age for screenable cancers toward younger populations. This study examines this shift in Sulaymaniyah city, Iraq, over the last 12 years, in comparison to the data of developed and regional countries.

Methods: A study was conducted on the data collected from health facilities in Sulaymaniyah. It focused on breast, colon, lung, prostate, and cervix cancers between the years 2011 and 2022.

Results: The typical age at which these five malignancies were diagnosed decreased significantly in Sulaymaniyah. (P-value less than 0.001). The most noticeable changes were in prostate and colon/rectum cancers. Compared to nearby and advanced countries, Sulaymaniyah's average ages of occurrence were mostly lower. This indicates that there is a local trend or early detection methods in practice in this region.

Conclusion: The study shows a big drop in average age of cancers found on screens in Sulaymaniyah. This implies that it is imperative to reevaluate cancer screening and prevention strategies, as the number young people falling ill has increased relative to previous years.

PDF
PDF

Metrics

Metrics Loading ...

References

  1. Hussain AM, Lafta RK. Cancer Trends in Iraq 2000-2016 Oman Med J. 2021; 36(1):e219. doi: 10.5001/omj.2021.18
  2. Khoshnaw N, Mohammed HA, Abdullah DA. Patterns of Cancer in Kurdistan - Results of Eight Years Cancer Registration in Sulaymaniyah Province-Kurdistan-Iraq. Asian Pac J Cancer Prev. 2015; 16(18):8525-31. doi: 10.7314/apjcp.2015.16.18.8525
  3. Shao Q, Tao R, Luca MM. The Effect of Urbanization on Health Care Expenditure: Evidence From China. Front Public Health. 2022; 10:850872. doi: 10.3389/fpubh.2022.850872
  4. Roshandel G, Ferlay J, Semnani S, Fazel A, Naeimi-Tabiei M, Ashaari M, et al. Recent cancer incidence trends and short-term predictions in Golestan, Iran 2004-2025 Cancer Epidemiol. 2020; 67:101728. doi: 10.1016/j.canep.2020.101728
  5. K MA, Abdullah OS, Amin AMS, Mohamed ZA, Hasan B, Shekha M, et al. Cancer Incidence in the Kurdistan Region of Iraq: Results of a Seven-Year Cancer Registration in Erbil and Duhok Governorates. Asian Pac J Cancer Prev. 2022; 23(2):601-15.doi: 10.31557/APJCP.2022.23.2.601
  6. Wang K, Liu Y, Mashrur SM, Loa P, Habib KN. COVid-19 influenced households' Interrupted Travel Schedules (COVHITS) survey: Lessons from the fall 2020 cycle. Transp Policy (Oxf). 2021; 112:43-62.doi: 10.1016/j.tranpol.2021.08.009
  7. Collaborators GBDAYAC. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Oncol. 2022; 23(1):27-52. doi: 10.1016/S1470-2045(21)00581-7
  8. Vierboom YC, Preston SH, Hendi AS. Rising geographic inequality in mortality in the United States. SSM Popul Health. 2019; 9:100478. doi: 10.1016/j.ssmph.2019.100478
  9. da Costa Vieira RA, Biller G, Uemura G, Ruiz CA, Curado MP. Breast cancer screening in developing countries. Clinics (Sao Paulo). 2017; 72(4):244-53. doi: 10.6061/clinics/2017(04)09
  10. 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) : Washington, D.C., USA. 7-11 November 2018. J Immunother Cancer. 2018; 6(Suppl 1):115. doi: 10.1186/s40425-018-0423-x
  11. Azamjah N, Soltan-Zadeh Y, Zayeri F. Global Trend of Breast Cancer Mortality Rate: A 25-Year Study. Asian Pac J Cancer Prev. 2019; 20(7):2015-20. doi: 10.31557/APJCP.2019.20.7.2015
  12. Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018; 30(2):144-50. doi: 10.1097/BOR.0000000000000480
  13. Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020; 40(5):602-8. doi: 10.1080/01443615.2019.1634030
  14. Menassa M, Stronks K, Khatmi F, Roa Diaz ZM, Espinola OP, Gamba M, et al. Concepts and definitions of healthy ageing: a systematic review and synthesis of theoretical models. E Clinical Medicine. 2023; 56:101821. doi: 10.1016/j.eclinm.2022.101821
  15. Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022; 8(3):420-44. doi: 10.1001/jamaoncol.2021.6987
How to Cite
Rashid Mahmud, D. (2025). Shifting the mean incident age for the five screenable cancers in Sulaymaniyah city-Iraq toward the younger age group, as a single-city experience for the last 12 years. Zanco Journal of Medical Sciences (Zanco J Med Sci), 29(2), 318–327. https://doi.org/10.15218/zjms.2025.033

Send mail to Author

Send Cancel